BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20881560)

  • 1. Repeat transsphenoidal surgery for the treatment of remaining or recurring pituitary tumors in acromegaly.
    Yamada S; Fukuhara N; Oyama K; Takeshita A; Takeuchi Y
    Neurosurgery; 2010 Oct; 67(4):949-56. PubMed ID: 20881560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
    Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
    Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone response to oral glucose before and after transfrontal pituitary surgery and radiotherapy in acromegaly.
    Dash RJ; Saini JS; Chander S; Kak VK; Ayyagari S
    J Assoc Physicians India; 1986 Mar; 34(3):171-3. PubMed ID: 3015867
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neurosurgical treatment of acromegaly].
    Astrup J; Kjaersgaard JO; Damsgaard EM
    Ugeskr Laeger; 1993 Jul; 155(27):2142-7. PubMed ID: 8328067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Plöckinger U; Quabbe HJ
    Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of acromegaly by transsphenoidal surgery.
    Tucker HS; Grubb SR; Wigand JP; Watlington CO; Blackard WG; Becker DP
    Arch Intern Med; 1980 Jun; 140(6):795-802. PubMed ID: 7387274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rathke's cleft cysts within a growth hormone producing pituitary adenoma.
    Nishio S; Fujiwara S; Morioka T; Fukui M
    Br J Neurosurg; 1995; 9(1):51-5. PubMed ID: 7786427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low incidence of adrenal insufficiency after transsphenoidal surgery in patients with acromegaly: a long-term follow-up study.
    Burgers AM; Kokshoorn NE; Pereira AM; Roelfsema F; Smit JW; Biermasz NR; Romijn JA
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1163-70. PubMed ID: 21470989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acromegaly-gigantism. Surgical treatment by transsphenoidal exeresis of the pituitary adenoma. Postoperative clinical and biological evaluation and therapeutic results].
    Somma M; Lanthier A
    Neurochirurgie; 1973 May; 19(2):Suppl 2:101-16. PubMed ID: 4752174
    [No Abstract]   [Full Text] [Related]  

  • 10. 10 years follow-up of transsphenoidal pituitary surgery in acromegaly.
    Knappe G; Rohde W; Mennig H; Gerl H
    Endokrinologie; 1982 Jul; 79(3):423-7. PubMed ID: 7128555
    [No Abstract]   [Full Text] [Related]  

  • 11. Transphenoidal microsurgery for acromegaly. Successful treatment with preservation of pituitary function.
    Becker DP; Atkinson R; Sakalas R; Vries JK; Young HF; Vines FS; Martinez J
    Confin Neurol; 1974; 36(2):101-5. PubMed ID: 4824576
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment outcomes and mortality of 94 patients with acromegaly.
    Trepp R; Stettler C; Zwahlen M; Seiler R; Diem P; Christ ER
    Acta Neurochir (Wien); 2005 Mar; 147(3):243-51; discussion 250-1. PubMed ID: 15627919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Control of thyrotrophic and corticotrophic functions in acromegaly].
    Jaquet P; Pelletier PA; Vague P; Sedan R
    Neurochirurgie; 1973 Nov; 19(6):531-6. PubMed ID: 4364516
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictors of outcome following Gamma Knife surgery for acromegaly.
    Poon TL; Leung SC; Poon CY; Yu CP
    J Neurosurg; 2010 Dec; 113 Suppl():149-152. PubMed ID: 21222293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of neuronavigation in transnasal transsphenoidal pituitary surgery.
    Thomale UW; Stover JF; Unterberg AW
    Zentralbl Neurochir; 2005 Aug; 66(3):126-32; discussion 132. PubMed ID: 16116555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acromegaly--diagnosis and treatment].
    Bollerslev J
    Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2534-8. PubMed ID: 11070991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide in the management of active acromegaly due to inoperable growth hormone-secreting adenoma.
    Candrina R
    Recenti Prog Med; 1994 Jan; 85(1):13-9. PubMed ID: 8184174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors.
    Shi Y; Tang D; Deng J; Su C
    Chin Med J (Engl); 1998 Oct; 111(10):891-4. PubMed ID: 11189233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cure of acromegaly by resection of pituitary tumor. Reestablishment of normal growth hormone secretion].
    Bachelot I; Muller JM; de Rougemont J; Tourniaire J
    Nouv Presse Med; 1973 Dec; 2(44):2945-8. PubMed ID: 4775176
    [No Abstract]   [Full Text] [Related]  

  • 20. Invasive pituitary tumor producing acromegaly, extreme elevation of growth hormone, and abnormal growth in tissue culture.
    Crowell RM; Kjellberg RN; Kliman B; Kornblith PL
    Neurochirurgia (Stuttg); 1974 Jul; 17(4):129-35. PubMed ID: 4437693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.